Cargando…
Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment
The angiogenesis inhibitor ramucirumab (IMC-1121B) is a fully humanised IgG1 monoclonal antibody targeting the extracellular domain of vascular endothelial growth factor receptor 2. Ramucirumab has been approved as a second-line treatment for lung cancer. Pyogenic granuloma is an acquired, benign va...
Autores principales: | Ibe, Tatsuya, Hamamoto, Yoichiro, Takabatake, Mikage, Kamoshida, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887457/ https://www.ncbi.nlm.nih.gov/pubmed/31776151 http://dx.doi.org/10.1136/bcr-2019-231464 |
Ejemplares similares
-
Methotrexate-associated lymphoproliferative disease with multiple pulmonary nodules in a patient with rheumatoid arthritis
por: Lai, Wei-Fu, et al.
Publicado: (2017) -
IgG4-related disease coexisting with autoimmune haemolytic anaemia
por: Wang, Kai-Chun, et al.
Publicado: (2018) -
Severe capillary leak syndrome with cardiac arrest triggered by influenza virus infection
por: Ebdrup, Lotte, et al.
Publicado: (2018) -
Uterine torsion and subsequent rupture in a gravid bicornuate uterus associated with an elevated alpha-fetoprotein
por: LaHood, Jennah, et al.
Publicado: (2018) -
Converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation
por: Suginobe, Hidehiro, et al.
Publicado: (2017)